SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-099701
Filing Date
2022-09-13
Accepted
2022-09-13 17:02:30
Documents
13
Period of Report
2022-09-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2225677d1_8k.htm   iXBRL 8-K 29472
2 EXHIBIT 99.1 tm2225677d1_ex99-1.htm EX-99.1 16770
  Complete submission text file 0001104659-22-099701.txt   226124

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA epix-20220913.xsd EX-101.SCH 3039
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE epix-20220913_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epix-20220913_pre.xml EX-101.PRE 22599
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2225677d1_8k_htm.xml XML 3687
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37410 | Film No.: 221241384
SIC: 2834 Pharmaceutical Preparations